Exin Therapeutics AI Discovery Platform

Drug discovery and biotech · by Exin Therapeutics, Inc.

A target discovery platform for neurotherapeutics that uses multimodal AI to predict drug candidate potential on multiple neural disorders simultaneously.

What it does

A target discovery platform for neurotherapeutics that uses multimodal AI to predict drug candidate potential on multiple neural disorders simultaneously. The platform is agnostic to therapeutic modality and focuses on neural circuits across various disorders.

Exin is developing a neurotherapeutic target-discovery platform focused on neural circuits across disorders. Its multimodal AI predicts drug candidates' potential across multiple neural disorders simultaneously. The platform is agnostic to therapeutic modality.

  • Target discovery for neurotherapeutics
  • Multimodal AI prediction of drug candidate potential
  • Discovery of next-generation neurotherapeutics
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
Pharmaceutical companies, Biotechnology firms, Neurotherapeutic researchers
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Exin Therapeutics, Inc. doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

Exin Therapeutics, Inc. hasn't published certifications or security practices for Exin Therapeutics AI Discovery Platform that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use Exin Therapeutics AI Discovery Platform at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Exin Therapeutics AI Discovery Platform